HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusions
- PMID: 34615987
- PMCID: PMC8550944
- DOI: 10.1038/s41375-021-01436-6
HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusions
Abstract
Gene fusions have been discussed in the scientific literature since they were first detected in cancer cells in the early 1980s. There is currently no standardized way to denote the genes involved in fusions, but in the majority of publications the gene symbols in question are listed either separated by a hyphen (-) or by a forward slash (/). Both types of designation suffer from important shortcomings. HGNC has worked with the scientific community to determine a new, instantly recognizable and unique separator-a double colon (::)-to be used in the description of fusion genes, and advocates its usage in all databases and articles describing gene fusions.
© 2021. The Author(s).
Conflict of interest statement
MLB is a member of the Board of Directors of the American Cancer Society and a member of the ACS Cancer Action Network; RV is a co-founder of, and has received research funding from, Boundless Bio.
Figures
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
